<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK6816" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK6816/" /><meta name="ncbi_pagename" content="Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/05/23" /><meta name="citation_author" content="Nancy D Leslie" /><meta name="citation_author" content="C Alexander Valencia" /><meta name="citation_author" content="Arnold W Strauss" /><meta name="citation_author" content="Kejian Zhang" /><meta name="citation_pmid" content="20301763" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK6816/" /><meta name="citation_keywords" content="Very Long-Chain Acyl-CoA Dehydrogenase Deficiency" /><meta name="citation_keywords" content="VLCAD Deficiency" /><meta name="citation_keywords" content="VLCAD Deficiency" /><meta name="citation_keywords" content="Very Long-Chain Acyl-CoA Dehydrogenase Deficiency" /><meta name="citation_keywords" content="Very long-chain specific acyl-CoA dehydrogenase, mitochondrial" /><meta name="citation_keywords" content="ACADVL" /><meta name="citation_keywords" content="Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Nancy D Leslie" /><meta name="DC.Contributor" content="C Alexander Valencia" /><meta name="DC.Contributor" content="Arnold W Strauss" /><meta name="DC.Contributor" content="Kejian Zhang" /><meta name="DC.Date" content="2019/05/23" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK6816/" /><meta name="description" content="Deficiency of very long-chain acyl-CoA dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial β-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms." /><meta name="og:title" content="Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Deficiency of very long-chain acyl-CoA dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial β-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK6816/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/vlcad/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK6816/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CC7C3E040F1110000000001920088.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK6816_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK6816_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/eds4/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vhl/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK6816_"><span class="title" itemprop="name">Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Very Long-Chain Acyl-CoA Dehydrogenase Deficiency, VLCAD Deficiency</div><p class="contrib-group"><span itemprop="author">Nancy D Leslie</span>, MD, <span itemprop="author">C Alexander Valencia</span>, PhD, <span itemprop="author">Arnold W Strauss</span>, MD, and <span itemprop="author">Kejian Zhang</span>, MD, MBA.</p><a data-jig="ncbitoggler" href="#__NBK6816_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK6816_ai__"><div class="contrib half_rhythm"><span itemprop="author">Nancy D Leslie</span>, MD<div class="affiliation small">Professor of Clinical Pediatrics<br />Division of Human Genetics<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@eilsel.ycnan" class="oemail">gro.cmhcc@eilsel.ycnan</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">C Alexander Valencia</span>, PhD<div class="affiliation small">Assistant Professor of Clinical Pediatrics<br />Division of Human Genetics<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@aicnelav.rednaxela" class="oemail">gro.cmhcc@aicnelav.rednaxela</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Arnold W Strauss</span>, MD<div class="affiliation small">Professor of Pediatrics<br />Heart Institute<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@ssuarts.dlonra" class="oemail">gro.cmhcc@ssuarts.dlonra</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kejian Zhang</span>, MD, MBA<div class="affiliation small">Associate Professor of Clinical Pediatrics<br />Division of Human Genetics<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@gnahz.naijek" class="oemail">gro.cmhcc@gnahz.naijek</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 28, 2009</span>; Last Revision: <span itemprop="dateModified">May 23, 2019</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="vlcad.Summary" itemprop="description"><h2 id="_vlcad_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Deficiency of very long-chain acyl-CoA dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial &#x003b2;-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis is established in an individual with abnormal acylcarnitine analysis on biochemical testing and/or identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ACADVL</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. If one <i>ACADVL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found and suspicion of VLCAD deficiency is high, specialized biochemical testing using cultured fibroblasts or lymphocytes may be needed for confirmation of the diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Use of intravenous (IV) glucose as an energy source, treatment of cardiac rhythm disturbance, and monitoring of rhabdomyolysis. Cardiac dysfunction may be reversible with early, intensive supportive care (occasionally including extracorporeal membrane oxygenation) and diet modification.</p><p><i>Prevention of primary manifestations:</i> Individuals with the more severe forms are typically placed on a low-fat formula, with supplemental calories provided through medium-chain triglycerides. Clinical trials of triheptanoin have shown some potential benefit for exercise tolerance.</p><p><i>Prevention of secondary complications:</i> Acute rhabdomyolysis is treated with ample hydration and alkalization of the urine to protect renal function and to prevent acute renal failure secondary to myoglobinuria.</p><p><i>Surveillance:</i> Suggested evaluations include annual physical exam including cardiac status, echocardiography on an annual or biannual basis, and annual assessment of nutritional status to avoid obesity, which can become a significant, difficult-to-manage problem in this disorder.</p><p><i>Agents/circumstances to avoid:</i> Fasting, myocardial irritation, dehydration, and high-fat diet, volatile anesthetics and those that contain high doses of long-chain fatty acids such as propofol and etomidate.</p><p><i>Evaluation of relatives at risk:</i> Evaluation of older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to identify those who would benefit from institution of treatment and preventive measures.</p><p><i>Pregnancy management:</i> Labor and postpartum periods are catabolic states and place the mother at higher risk for rhabdomyolysis and subsequent myoglobinuria. A management plan for labor and delivery is necessary for the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> pregnant woman.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>VLCAD deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div class="h2"></div><p> [Au: Update the author information below as needed. List the authors in the order in which the names should appear in the posted entry.]</p><div id="vlcad.Diagnosis"><h2 id="_vlcad_Diagnosis_">Diagnosis</h2><p>Very long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the initial step of mitochondrial &#x003b2;-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons. VLCAD deficiency is associated with a range of phenotypes:</p><ul><li class="half_rhythm"><div>Severe early-onset cardiac and multiorgan failure form</div></li><li class="half_rhythm"><div>Hepatic or hypoketotic hypoglycemic form</div></li><li class="half_rhythm"><div>Later-onset episodic myopathic form with intermittent rhabdomyolysis</div></li></ul><div id="vlcad.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>Newborn screening test abnormality suggestive of VLCAD deficiency</div></li><li class="half_rhythm"><div>Cardiac abnormality. Severe early-onset hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias accompanied by hypotonia, hepatomegaly, and intermittent hypoglycemia</div></li><li class="half_rhythm"><div>Severe early-onset multiorgan failure</div></li><li class="half_rhythm"><div>Hepatic dysfunction associated with hepatomegaly and hypoglycemia out of proportion to the duration of fasting and/or unaccompanied by large ketones in the urine, but without cardiomyopathy. Lab testing may identify elevated transaminases or altered hepatic synthetic function.</div></li><li class="half_rhythm"><div>Myopathy associated with exercise intolerance, muscle cramps and/or pain and episodic intermittent rhabdomyolysis provoked by strenuous exercise, fasting, cold exposure, or fever; intermittent elevations in creatine phosphokinase (CK) with return to normal between episodes</div></li></ul></div><div id="vlcad.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of VLCAD deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with abnormal acylcarnitine analysis on biochemical testing and/or identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ACADVL</i> on <a href="#vlcad.Molecular_Genetic_Testing">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK6816/table/vlcad.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figvlcadTmoleculargenetictestingusedi" rid-ob="figobvlcadTmoleculargenetictestingusedi">Table 1</a>). <a href="#vlcad.Specialized_Biochemical_Testing">Specialized biochemical testing</a> may be necessary if only a single <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ACADVL</i> is identified.</p><div id="vlcad.Biochemical_Testing"><h4>Biochemical Testing</h4><p><b>Population-based <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a></b> using MS/MS technology has identified numerous <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#vlcad.REF.boneh.2006.166">Boneh et al 2006</a>, <a class="bk_pop" href="#vlcad.REF.merritt.2014.484">Merritt et al 2014</a>]:</p><ul><li class="half_rhythm"><div class="half_rhythm">All abnormal results on <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (NBS) should be followed by a confirmatory acylcarnitine profile as well as <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> [<a class="bk_pop" href="#vlcad.REF.boneh.2006.166">Boneh et al 2006</a>]. See <a href="http://www.acmg.net/PDFLibrary/C14-1-Elevated-Algorithm.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACMG Algorithm</a>, <a href="http://www.acmg.net/PDFLibrary/C14.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACMG NBS ACT Sheet</a>.</div><div class="half_rhythm">Note: A significant number of individuals with an abnormal newborn screen have one <i>ACADVL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and are likely heterozygotes (i.e., carriers) detected because of the low specificity of the initial NBS acylcarnitine screening assay unless multiple marker calculations are applied [<a class="bk_pop" href="#vlcad.REF.diekman.2016.101">Diekman et al 2016</a>].</div></li></ul><p><b>Acylcarnitine analysis.</b> The key metabolites that are most often abnormal in VLCAD deficiency are C14:1, C14:2, C14, and C12:1 [<a class="bk_pop" href="#vlcad.REF.mchugh.2011.230">McHugh et al 2011</a>]. Plasma or dried blood spot comprehensive acylcarnitine analysis using tandem mass spectrometry and measuring C4-C20 straight-chain acyl-carnitine esters, 3-hydroxy-acyl carnitine esters, and unsaturated acyl-carnitine esters is most sensitive when collected during a period of metabolic stress, such as fasting.</p><ul><li class="half_rhythm"><div>Although cutoff/abnormal values vary by age, method of collection, and laboratory, a C14:1 level &#x0003e;1 mmol/L [<a class="bk_pop" href="#vlcad.REF.miller.2015.139">Miller et al 2015</a>] on an initial <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> test strongly suggests VLCAD deficiency. Individuals with this level or higher should be assumed to have VLCAD deficiency.</div></li><li class="half_rhythm"><div>Levels of C14:1 &#x0003e;0.8 mmol/L suggest VLCAD deficiency but may also occur in carriers and some healthy individuals having no <i>ACADVL</i> pathogenic variants.</div></li><li class="half_rhythm"><div>Post-analytic tools, such as those developed by the Region 4 Stork (R4S/CLIR) collaborative, may contribute to refinement of <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> cutoffs and inform clinicians regarding the likelihood of a true positive diagnosis of VLCAD in individual newborns [<a class="bk_pop" href="#vlcad.REF.hall.2014.889">Hall et al 2014</a>, <a class="bk_pop" href="#vlcad.REF.merritt.2014.484">Merritt et al 2014</a>].</div></li></ul><p>Note: (1) Diagnostic abnormalities may no longer be present if an individual has been fed or has been treated with an IV glucose infusion or if the episode prompting concern has resolved. (2) Newborn screening data have affirmed that acylcarnitine analysis during periods of physiologic wellness often fails to identify <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have the milder phenotypes. (3) Depending on the "cutoff" limits used, initial acylcarnitine screening often detects heterozygotes (unaffected carriers) [<a class="bk_pop" href="#vlcad.REF.miller.2015.139">Miller et al 2015</a>].</p><p><b>Postmortem testing.</b> The following have been used to identify fatty acid oxidation (FAO) disorders postmortem:</p><ul><li class="half_rhythm"><div>Biochemical testing of liver or bile for acylcarnitine elevations and histochemical analysis for microvesicular steatosis</div></li><li class="half_rhythm"><div>Studies on a postmortem skin biopsy</div></li><li class="half_rhythm"><div>Elevated concentrations of C8-C16 free fatty acids in plasma</div></li></ul><p>If these analyses are suspicious, retrospective molecular genetic and biochemical testing of newborn blood spots can often be performed to confirm a diagnosis.</p></div><div id="vlcad.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>. A multigene panel is used primarily when the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may be attributed to VLCAD deficiency in addition to other conditions and biochemical data is unclear or unlikely to be clear &#x02013; for example, during the evaluation of an adult with intermittent rhabdomyolysis.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ACADVL</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ACADVL</i> and other genes of interest (see <a href="#vlcad.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><p>Note: If one <i>ACADVL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found and suspicion of VLCAD deficiency is high, functional assessment of &#x003b2;-oxidation through the in vitro probe study or direct VLCAD enzyme activity assay using protein extracts from cultured fibroblasts or lymphocytes is recommended. See <a href="#vlcad.Specialized_Biochemical_Testing">Specialized Biochemical Testing</a>.</p><div id="vlcad.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in VLCAD Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6816/table/vlcad.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vlcad.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACADVL</i></td><td headers="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_vlcad.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare; only one reported&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="vlcad.TF.1.1"><p class="no_margin">See <a href="/books/NBK6816/#vlcad.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="vlcad.TF.1.2"><p class="no_margin">See <a href="#vlcad.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="vlcad.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="vlcad.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#vlcad.REF.miller.2015.139">Miller et al [2015]</a>, <a class="bk_pop" href="#vlcad.REF.pena.2016.272">Pena et al [2016]</a></p></div></dd><dt>5. </dt><dd><div id="vlcad.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="vlcad.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#vlcad.REF.pervaiz.2011.29">Pervaiz et al [2011]</a>, <a class="bk_pop" href="#vlcad.REF.miller.2015.139">Miller et al [2015]</a></p></div></dd></dl></div></div></div></div><div id="vlcad.Specialized_Biochemical_Testing"><h4>Specialized Biochemical Testing</h4><p>Specialized biochemical testing may be used to clarify the diagnosis, particularly when molecular testing reveals only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Analysis of fatty acid &#x003b2;-oxidation in cultured fibroblasts.</b> In vitro incubation of cultured fibroblasts with C13-palmitate or unlabeled palmitate and carnitine may provide indirect evidence of impaired &#x003b2;-oxidation. Individuals with severe VLCAD deficiency typically accumulate excess tetradecanoyl (C14) carnitine, whereas individuals with less severe phenotypes may shift accumulation toward dodecanoyl (C12) carnitine. This test is often called the "in vitro probe study" and is available clinically.</p><p><b>Analysis of VLCAD enzyme activity.</b> Measurement of VLCAD enzyme activity in leukocytes, cultured fibroblasts, liver, heart, skeletal muscle, or amniocytes by the electron transfer flavoprotein or ferricineum reduction assay can be used to confirm the diagnosis of VLCAD deficiency. Better specificity has been noted when the products are separated and quantitated by high-performance liquid chromatography or tandem mass spectrometry (MS/MS). The clinical availability of this assay has varied with time.</p><p><b>Immunoreactive VLCAD protein antigen expression</b> (an "immunoblot"). This test uses polyclonal, specific antibodies to make a semi-quantitative assessment of expressed VLCAD antigen levels in protein extracts derived from cultured fibroblasts. Levels lower than 10% of control are consistent with VLCAD deficiency.</p><p>This assay may be available only in a research setting.</p></div></div></div><div id="vlcad.Clinical_Characteristics"><h2 id="_vlcad_Clinical_Characteristics_">Clinical Characteristics</h2><div id="vlcad.Clinical_Description"><h3>Clinical Description</h3><p>Three clinical groups of VLCAD deficiency have been reported [<a class="bk_pop" href="#vlcad.REF.andresen.1999.479">Andresen et al 1999</a>].</p><p><b>Severe early-onset cardiac and multiorgan failure VLCAD deficiency</b> typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia.</p><p>Cardiomyopathy and arrhythmias are often lethal. Ventricular tachycardia, ventricular fibrillation, and atrioventricular block have been reported [<a class="bk_pop" href="#vlcad.REF.bonnet.1999.2248">Bonnet et al 1999</a>]. Although the morbidity resulting from cardiomyopathy may be severe, cardiac dysfunction may be reversible with early intensive supportive care and diet modification; normal cognitive outcome has been reported in these individuals. Both <a class="bk_pop" href="#vlcad.REF.pena.2016.272">Pena et al [2016]</a> and <a class="bk_pop" href="#vlcad.REF.vockley.2016.223">Vockley et al [2016]</a> reported individuals who developed cardiomyopathy while being treated with a medium-chain triglyceride (MCT) oil-based diet.</p><p><b>Hepatic or hypoketotic hypoglycemic VLCAD</b>
<b>deficiency</b> typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly (similar to MCAD deficiency) but without cardiomyopathy. Hypoglycemia and poor feeding during the newborn period have been reported in neonates who were later diagnosed with VLCAD deficiency [<a class="bk_pop" href="#vlcad.REF.pena.2016.272">Pena et al 2016</a>].</p><p><b>Later-onset episodic myopathic</b>
<b>VLCAD</b>
<b>deficiency,</b> probably the most common <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms in these individuals. Ascertainment in adulthood has been reported [<a class="bk_pop" href="#vlcad.REF.hoffman.2006.657">Hoffman et al 2006</a>].</p></div><div id="vlcad.Pathophysiology"><h3>Pathophysiology</h3><p>The fatty acid oxidation (FAO) spiral is a series of four reactions occurring in the mitochondrial matrix. The first step is catalyzed by four highly homologous, straight-chain acyl-CoA dehydrogenases with differing, but overlapping, substrate specificities:</p><ul><li class="half_rhythm"><div>Short (SCAD that uses C4-C6 fatty acyl-CoAs)</div></li><li class="half_rhythm"><div>Medium (MCAD; C6-C10 fatty acyl-CoAs)</div></li><li class="half_rhythm"><div>Long (LCAD; C10-C14 fatty acyl-CoAs)</div></li><li class="half_rhythm"><div>Very long (VLCAD; C14-C20 fatty acyl-CoAs)</div></li></ul><p>SCAD, MCAD, and LCAD are homotetramers localized to the mitochondrial matrix; VLCAD is a homodimer associated with the inner mitochondrial membrane. These four homologs share about 40% amino acid identity or similarity within the catalytic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>; all use flavin adenine dinucleotide as the electron-accepting cofactor. Electrons are fed into the electron transport chain via ETF and ETF dehydrogenase.</p><p>With every turn of the &#x003b2;-oxidation spiral, the chain length is shortened by two carbon atoms. Reactions distal to the long-chain acyl-CoA dehydrogenase (LCAD) include those catalyzed by the LCHAD/trifunctional protein, including a hydratase step, dehydrogenase step, and thiolase step.</p><p>The use of fat to supply energy is important at critical points of physiologic adaptation. In utero, the fetus derives a constant supply of energy from glucose supplied continuously via the placenta. Following birth, maternal milk (of which ~60% of calories are fat) becomes the major nutrient, and therefore, fat becomes the major energy source, especially in the heart and in other highly oxidative organs including kidney and skeletal muscle [<a class="bk_pop" href="#vlcad.REF.hale.1985.666">Hale et al 1985</a>, <a class="bk_pop" href="#vlcad.REF.aoyama.1993.1369">Aoyama et al 1993</a>].</p><p>The heart constantly uses fatty acids for energy. In contrast, the liver uses nutrients delivered directly during the absorptive phase of digestion and controls the short- and medium-term storage and distribution of energy from glycogenolysis and gluconeogenesis. However, during longer periods of fasting, the liver uses acetyl CoA to generate ketone bodies. The brain adapts to fasting by switching to a ketone economy, reducing the need for glucose as the energy source. With exercise, especially prolonged exercise, slow skeletal muscles use longer-chain FAO to generate energy. In summary, the adaptation to fasting depends on the supply of energy, the rate of consumption and preferred substrate, and physiologic backup mechanisms to provide alternative sources of energy in times of stress or transition.</p><p>As one of the first enzymes in the FAO spiral, the enzyme VLCAD controls a critical point in the supply of electrons to the respiratory chain, and also provides a pathway permissive to the production of ketones. It would be expected that significant reduction at this step of fatty acid oxidation would impair the ability to transition successfully from fetal to neonatal life, to maintain cardiac output, to adapt to long fasting, and to generate energy for exercise. All of the above difficulties have been observed in VLCAD deficiency. The most severe defects result in early-infantile cardiomyopathy, hepatomegaly, hypotonia, and intermittent hypoglycemia.</p></div><div id="vlcad.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>As a general rule, a strong <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation exists in VLCAD deficiency [<a class="bk_pop" href="#vlcad.REF.andresen.1999.479">Andresen et al 1999</a>]:</p><ul><li class="half_rhythm"><div>Severe disease is associated with no residual enzyme activity, often resulting from <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants. Approximately 81% of pathogenic truncating variants in <i>ACADVL</i> are associated with the severe early-onset form [<a class="bk_pop" href="#vlcad.REF.andresen.1999.479">Andresen et al 1999</a>]. Specific <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants leading to low long-chain fatty acid oxidation flux may also be associated with cardiac disease [<a class="bk_pop" href="#vlcad.REF.diekman.2015.989">Diekman et al 2015</a>].</div></li><li class="half_rhythm"><div>Milder childhood and adult forms are often associated with residual enzyme activity. The common <a class="figpopup" href="/books/NBK6816/table/vlcad.T.selected_acadvl_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figvlcadTselectedacadvlpathogenicvaria" rid-ob="figobvlcadTselectedacadvlpathogenicvaria">p.Val283Ala</a> variant, in both <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> and <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> genotypes, is typically associated with the non-cardiac phenotypes [<a class="bk_pop" href="#vlcad.REF.spiekerkoetter.2009.498">Spiekerkoetter et al 2009</a>, <a class="bk_pop" href="#vlcad.REF.diekman.2015.989">Diekman et al 2015</a>, <a class="bk_pop" href="#vlcad.REF.miller.2015.139">Miller et al 2015</a>].</div></li></ul></div><div id="vlcad.Penetrance"><h3>Penetrance</h3><p>Severe forms are suspected to be fully penetrant.</p><p>Since the later-onset forms may have vague or intermittent symptoms, it is possible that some individuals will have no recognizable symptoms during their lifetime.</p></div><div id="vlcad.Nomenclature"><h3>Nomenclature</h3><p>When the severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of VLCAD deficiency was described initially by <a class="bk_pop" href="#vlcad.REF.hale.1985.666">Hale et al [1985]</a>, it was attributed to deficiency of the enzyme LCAD. The correct identification of the deficient enzyme, VLCAD, was made by <a class="bk_pop" href="#vlcad.REF.aoyama.1993.1369">Aoyama et al [1993]</a>.</p></div><div id="vlcad.Prevalence"><h3>Prevalence</h3><p>Complete ascertainment by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> is not assured, but the incidence of VLCAD deficiency is now estimated at 1:30,000 to 1:100,000 births. More than 800 cases have been reported (clir-R4S.org consortium data, updated June 2017) [<a class="bk_pop" href="#vlcad.REF.mchugh.2011.230">McHugh et al 2011</a>] (<a href="http://www.nature.com/gim/journal/v13/n3/full/gim9201145a.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><p>Newborn screening has demonstrated that VLCAD deficiency is more prevalent than previously suspected; however, the majority of children ascertained by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> are asymptomatic during the few years of observation, suggesting that these individuals may have gone undiagnosed prior to the advent of population-based screening.</p></div></div><div id="vlcad.Genetically_Related_Allelic_Disord"><h2 id="_vlcad_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ACADVL</i><b>.</b></p></div><div id="vlcad.Differential_Diagnosis"><h2 id="_vlcad_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Infantile cardiomyopathy</b> with evidence of abnormal fatty acid oxidation may be seen in the following <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders [<a class="bk_pop" href="#vlcad.REF.roe.2006.40">Roe et al 2006</a>]:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/cdsp/">Systemic primary carnitine deficiency</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/cpt2/">Carnitine palmitoyltransferase II (CPT II) deficiency</a> &#x02013; severe infantile hepatocardiomuscular form</div></li><li class="half_rhythm"><div>Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) / trifunctional protein deficiency (OMIM <a href="http://omim.org/entry/609016" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609016</a>)</div></li><li class="half_rhythm"><div>Carnitine-acylcarnitine translocase deficiency (OMIM <a href="http://omim.org/entry/212138" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">212138</a>)</div></li><li class="half_rhythm"><div>Severe forms of multiple acyl-CoA dehydrogenase deficiency (OMIM <a href="http://omim.org/entry/231680" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">231680</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/tango2-mea/"><i>TANGO2</i>-related metabolic encephalopathy and arrhythmias</a></div></li></ul><p><b>The hepatic "hypoglycemic" form</b> of VLCAD deficiency may have clinical features similar to <a href="/books/n/gene/mcad/">medium-chain acyl CoA dehydrogenase (MCAD) deficiency</a>, or to the electron transfer flavoprotein (ETF)/ETF ubiquinone (coenzyme Q) oxidoreductase defects that produce multiple acyl-CoA dehydrogenase deficiencies; however, the biochemical phenotypes are distinct.</p><p><b>Intermittent rhabdomyolysis</b> is a feature of <a href="/books/n/gene/gsd5/">McArdle disease</a>, <a href="/books/n/gene/cpt2/">CPT II deficiency</a>, some primary myopathies, and trifunctional protein deficiency (OMIM <a href="http://omim.org/entry/609015" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609015</a>). Rhabdomyolysis is also seen in LPIN1 deficiency, though often at younger ages than in VLCAD deficiency and typically provoked by illness rather than exercise.</p></div><div id="vlcad.Management"><h2 id="_vlcad_Management_">Management</h2><div id="vlcad.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with VLCAD deficiency, the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Measurement of baseline plasma (serum) creatine kinase (CK) concentration</div></li><li class="half_rhythm"><div>Measurement of baseline liver transaminases</div></li><li class="half_rhythm"><div>Cardiac echocardiography</div></li><li class="half_rhythm"><div>Electrocardiogram</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p>Note: In the setting of acute disease, measurement of blood glucose concentration and blood ammonia concentration may be indicated.</p></div><div id="vlcad.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Frequently updated, succinct "emergency" care plans should detail the typical clinical issues (either those already experienced by the patient or those anticipated based on the diagnosis) and the importance of early management (e.g., use of IV glucose as an energy source, monitoring for cardiac rhythm disturbance, and monitoring of rhabdomyolysis), and avoidance of triggers (fasting, long-chain fats, and irritation of the myocardium) [<a class="bk_pop" href="#vlcad.REF.arnold.2009.85">Arnold et al 2009</a>].</p><p>Cardiac dysfunction may be reversible with early, intensive supportive care (occasionally including extracorporeal membrane oxygenation) and diet modification. See <a href="#vlcad.Prevention_of_Primary_Manifestatio">Prevention of Primary Manifestations</a>.</p></div><div id="vlcad.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>Individuals with the more severe forms of VLCAD deficiency are typically placed on a low-fat formula, with supplemental calories provided through medium-chain triglycerides (MCT). A variety of strategies for the low-fat diet are used, ranging from 13%-39% of calories as total fat, with an additional 15%-18% of calories supplied as MCT oil in those most strictly restricted for long-chain fats [<a class="bk_pop" href="#vlcad.REF.solis.2002.1800">Solis &#x00026; Singh 2002</a>].</p><p>Use of extra MCT has demonstrated benefit in older individuals with long-chain defects who have exercise intolerance. <a class="bk_pop" href="#vlcad.REF.gillingham.2006.58">Gillingham et al [2006]</a> demonstrated improved exercise tolerance in individuals given 0.5 g/kg lean body weight 20 minutes prior to exercise. [<a class="bk_pop" href="#vlcad.REF.behrend.2012.110">Behrend et al 2012</a>].</p><p>Triheptanoin has been used in a few individuals with the goal of providing calories as well as anaplerotic carbons. Formal clinical trials of triheptanoin are in progress (see <a href="#vlcad.Therapies_Under_Investigation">Therapies Under Investigation</a>). A retrospective analysis of individuals who developed cardiomyopathy and improved after intensive supportive care and a change from MCT to triheptanoin indicates some potential benefit [<a class="bk_pop" href="#vlcad.REF.vockley.2016.223">Vockley et al 2016</a>]. A Phase II open-label trial of the effect of triheptanoin on exercise tolerance showed some potential benefits. The major adverse effect was diarrhea [<a class="bk_pop" href="#vlcad.REF.vockley.2017.370">Vockley et al 2017</a>].</p><p>Severe exercise (e.g., military training) has unmasked symptoms in previously asymptomatic adults [<a class="bk_pop" href="#vlcad.REF.hoffman.2006.657">Hoffman et al 2006</a>, <a class="bk_pop" href="#vlcad.REF.lafor_t.2009.324">Lafor&#x000ea;t et al 2009</a>], emphasizing that exercise should be guided by the individual's tolerance level.</p><p>The use of carnitine supplementation is controversial [<a class="bk_pop" href="#vlcad.REF.arnold.2009.85">Arnold et al 2009</a>]: consensus as to whether additional carnitine is detrimental or efficacious has not been established. The major concern stems from studies in a mouse model of VLCAD deficiency. Mice given L-carnitine supplementation accumulated higher levels of long-chain acylcarnitines, of concern because of potential myocardial toxicity. In addition, in mice with VLCAD deficiency, the drop in muscle carnitine after exercise was not prevented by supplementation [<a class="bk_pop" href="#vlcad.REF.primassin.2008.632">Primassin et al 2008</a>]. The relevance of this mouse model to humans with VLCAD deficiency is controversial.</p></div><div id="vlcad.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Acute rhabdomyolysis is treated with ample hydration and alkalization of the urine to protect renal function and to prevent acute renal failure secondary to myoglobinuria.</p></div><div id="vlcad.Surveillance"><h3>Surveillance</h3><p>There are no current published guidelines for surveillance during interval health visits.</p><p>Suggested evaluations include:</p><ul><li class="half_rhythm"><div>Annual physical exam, including cardiac status</div></li><li class="half_rhythm"><div>Consideration of echocardiography on an annual or biannual basis, particularly in individuals with previous cardiac dysfunction or those with significant exercise intolerance</div></li><li class="half_rhythm"><div>Annual assessment of nutritional status. Obesity can become a significant problem, and is not easy to remedy in individuals with exercise intolerance and requirement for active management of fasting.</div></li><li class="half_rhythm"><div>Assessment of essential fatty acid deficiency, particularly in those individuals with severely restricted long-chain dietary fat</div></li></ul></div><div id="vlcad.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Fasting, including periods of preparation and recovery from planned surgery or sedation [<a class="bk_pop" href="#vlcad.REF.vellekoop.2011.96">Vellekoop et al 2011</a>]</div></li><li class="half_rhythm"><div>Myocardial irritation (e.g., cardiac catheterization)</div></li><li class="half_rhythm"><div>Dehydration (risk for acute tubular necrosis)</div></li><li class="half_rhythm"><div>High-fat diet (long-chain fats) including ketogenic or carbohydrate-restricted diets for the purpose of weight loss. Careful weight reduction has been accomplished by restricting long-chain fats and calories, supplementing with calories provided through medium-chain triglycerides (MCT), and limiting overnight catabolism with uncooked cornstarch [<a class="bk_pop" href="#vlcad.REF.zweers.2012.127">Zweers et al 2012</a>].</div></li><li class="half_rhythm"><div>Volatile anesthetics and those that contain high doses of long-chain fatty acids such as propofol and etomidate [<a class="bk_pop" href="#vlcad.REF.vellekoop.2011.96">Vellekoop et al 2011</a>]. However, the use of propofol for short-duration procedures has been evaluated in individuals with LCHAD deficiency and not found to cause adverse events [<a class="bk_pop" href="#vlcad.REF.martin.2014.139">Martin et al 2014</a>].</div></li></ul></div><div id="vlcad.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate the older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from institution of treatment and preventive measures (see Management, <a href="#vlcad.Prevention_of_Primary_Manifestatio">Prevention of Primary Manifestations</a>).</p><ul><li class="half_rhythm"><div>If the pathogenic variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk sibs.</div></li><li class="half_rhythm"><div>If the pathogenic variants in the family are not known, plasma or dried blood spot acylcarnitine analysis may not be sufficiently sensitive, and direct VLCAD assay of lymphocytes or FAO probe studies of cultured fibroblasts may be required.</div></li></ul><p>See <a href="#vlcad.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="vlcad.Pregnancy_Management"><h3>Pregnancy Management</h3><p>During pregnancy, placental and fetal &#x003b2;-oxidation may temporize or even improve maternal fatty acid &#x003b2;-oxidation [<a class="bk_pop" href="#vlcad.REF.mendezfigueroa.2010.558">Mendez-Figueroa et al 2010</a>]. However, labor and postpartum periods are catabolic states and place the mother at higher risk for rhabdomyolysis and subsequent myoglobinuria. A management plan for labor and delivery has been proposed by <a class="bk_pop" href="#vlcad.REF.mendezfigueroa.2010.558">Mendez-Figueroa et al [2010]</a>.</p></div><div id="vlcad.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Several clinical trials of triheptanoin are either in progress or recently completed [<a class="bk_pop" href="#vlcad.REF.vockley.2017.370">Vockley et al 2017</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="vlcad.Genetic_Counseling"><h2 id="_vlcad_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="vlcad.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>VLCAD deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="vlcad.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ACADVL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with VLCAD deficiency are obligate heterozygotes (carriers) for an <i>ACADVL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ACADVL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="vlcad.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p><p><b>Biochemical genetic testing.</b> Carrier status increases the likelihood of detection in a <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> program, as individuals with half of the normal VLCAD enzyme activity may have acylcarnitine levels near the upper limits of the normal range and the lower limits of the "possibly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>" range, particularly under the conditions of stress imposed by perinatal transition. However, testing of acylcarnitines, particularly in the unstressed individual, is not reliable for identifying heterozygotes.</p><p>Functional testing of fibroblasts, using the various protocols of palmitate oxidation and incorporation into small acylcarnitine species, also does not typically identify carriers.</p><p>A direct VLCAD enzyme assay may provide better evidence of a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> state than the options described above, but in most cases <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is preferred. In addition, the clinical availability of the VLCAD enzyme assay has varied with time.</p></div><div id="vlcad.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>The genetic status of full sibs should be determined, since many individuals with VLCAD deficiency are not symptomatic during early childhood. See Management, <a href="#vlcad.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="vlcad.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>ACADVL</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Biochemical genetic testing.</b> Prenatal diagnosis of VLCAD deficiency based on the pattern of incorporation of labeled carbons (ranging from palmitate into shorter chain acylcarnitines) by cultured amniocytes that is similar to the fibroblast in vitro acylcarnitine profile has been described. Assay of VLCAD enzyme activity can distinguish between <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and unaffected cells. Absence of immunoreactive VLCAD on western blot analysis in those with severe VLCAD deficiency should provide additional information. As experience with and clinical availability of these assays is limited in the US, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is preferred for prenatal testing.</p></div></div><div id="vlcad.Resources"><h2 id="_vlcad_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Very%20long-chain%20acyl-CoA%20dehydrogenase%20deficiency&#x00026;parent=Newborn%20Screening%20Conditions&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Very long-chain acyl-CoA dehydrogenase deficiency</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=verylongchainacylcoenzymeadehydrogenasedeficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"> Very long-chain acyl-coenzyme A dehydrogenase deficiency</a></div></li><li class="half_rhythm"><div><b>Save Babies Through Screening Foundation, Inc.</b></div><div>P. O. Box 42197</div><div>Cincinnati OH 45242</div><div><b>Phone:</b> 888-454-3383</div><div><b>Email:</b> email@savebabies.org</div><div><a href="http://www.savebabies.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.savebabies.org</a></div></li><li class="half_rhythm"><div><b>STAR-G (Screening, Technology and Research in Genetics)</b></div><div><b>Email:</b> info@newbornscreening.info</div><div><a href="http://www.newbornscreening.info/Parents/fattyaciddisorders/VLCADD.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Very long chain acyl-coenzyme A dehydrogenase</a></div></li><li class="half_rhythm"><div><b>FOD Family Support Group (Fatty Oxidation Disorder)</b></div><div>PO Box 54</div><div>Okemos MI 48805-0054</div><div><b>Phone:</b> 517-381-1940</div><div><b>Fax:</b> 866-290-5206 (toll-free)</div><div><b>Email:</b> deb@fodsupport.org; fodgroup@gmail.com</div><div><a href="http://www.fodsupport.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fodsupport.org</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li></ul></div><div id="vlcad.Molecular_Genetics"><h2 id="_vlcad_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="vlcad.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6816/table/vlcad.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vlcad.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_vlcad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_vlcad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_vlcad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_vlcad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_vlcad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_vlcad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_vlcad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/37" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ACADVL</i></a></td><td headers="hd_b_vlcad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=37" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17p13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_vlcad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P49748" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Very long-chain specific acyl-CoA dehydrogenase, mitochondrial</a></td><td headers="hd_b_vlcad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=ACADVL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (ACADVL)</a></td><td headers="hd_b_vlcad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ACADVL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACADVL</a></td><td headers="hd_b_vlcad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ACADVL[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACADVL</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="vlcad.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="vlcad.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency (<a href="/omim/201475,609575" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6816/table/vlcad.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vlcad.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/201475" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">201475</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609575" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609575</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN; ACADVL</td></tr></tbody></table></div></div><div id="vlcad.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Very long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the initial step of mitochondrial &#x003b2;-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons.</p><p><b>Gene structure.</b>
<i>ACADVL</i> comprises 20 exons spanning approximately 5.4 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK6816/#vlcad.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK6816/table/vlcad.T.selected_acadvl_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figvlcadTselectedacadvlpathogenicvaria" rid-ob="figobvlcadTselectedacadvlpathogenicvaria">Table 2</a>. Hundreds of pathogenic variants are known, including <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, and frameshift variants; they occur throughout the VLCAD protein.</p><p>The most common pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, c.848T&#x0003e;C (p.Val283Ala), is observed in symptomatic compound heterozygotes and in homozygotes. It accounts for approximately 10% [<a class="bk_pop" href="#vlcad.REF.miller.2015.139">Miller et al 2015</a>] to 29% [<a class="bk_pop" href="#vlcad.REF.pena.2016.272">Pena et al 2016</a>] of all pathogenic alleles among individuals detected by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>.</p><p>Recurring pathogenic variants have often been reported; however, their frequency has not been well established.</p><p>Racial and ethnic variants are reported. For example, p.Thr409Met is observed more commonly among individuals of Pacific Island ancestry than in other populations.</p><p>In vitro functional assays have been used to characterize putative pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and to investigate the clinical and biochemical aspects of VLCAD deficiency [<a class="bk_pop" href="#vlcad.REF.gobinlimballe.2007.1133">Gobin-Limballe et al 2007</a>, <a class="bk_pop" href="#vlcad.REF.goetzman.2007.138">Goetzman et al 2007</a>].</p><div id="vlcad.T.selected_acadvl_pathogenic_varia" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>ACADVL</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK6816/table/vlcad.T.selected_acadvl_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vlcad.T.selected_acadvl_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.848T&#x0003e;C</td><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val283Ala<br />(Val243Ala)</td><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_000018.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000018<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/entrez/viewer.fcgi?val=NP_000009.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000009<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.779C&#x0003e;T</td><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr260Met<br />(Thr220Met)</td></tr><tr><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1226C&#x0003e;T</td><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr409Met<br />(Thr369Met)</td></tr><tr><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1322G&#x0003e;A</td><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly441Asp<br />(Gly401Asp)</td></tr><tr><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1405C&#x0003e;T</td><td headers="hd_h_vlcad.T.selected_acadvl_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg469Trp<br />(Arg429Trp)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="vlcad.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions. Note: Earlier references used protein nomenclature consistent with the mature protein and are provided in parentheses.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mature VLCAD protein of 615 amino acids has a large, tightly conserved functional <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> common to the acyl-CoA dehydrogenases. The major isoform encodes a precursor protein of 655 amino acids with a mitochondrial targeting sequence of 40 amino acids that is removed during uptake, resulting in the mature membrane-associated protein of 615 amino acid residues as reported by <a class="bk_pop" href="#vlcad.REF.aoyama.1995.273">Aoyama et al [1995]</a> and <a class="bk_pop" href="#vlcad.REF.strauss.1995.10496">Strauss et al [1995]</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss of VLCAD enzyme activity causes disease. The majority of pathogenic variants reduce enzyme activity and/or result in reduced stability leading to lower steady state levels in mitochondria.</p></div></div><div id="vlcad.References"><h2 id="_vlcad_References_">References</h2><div id="vlcad.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.andresen.1999.479">Andresen BS, Olpin S, Poorthuis B, Scholte H, Vianey-Saban C, Wanders R, Ijlst L, Morris A, Pourfarzam M, Bartlett K, Baumgartner R, deKlerk J, Schroeder L, Corydon T, Lund H, Winter V, Bross P, Bolund L, Gregersen N. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:479–94.</span> [<a href="/pmc/articles/PMC1377757/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377757</span></a>] [<a href="/pubmed/9973285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9973285</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.aoyama.1995.273">Aoyama T, Souri M, Ueno I, Kamijo T, Yamaguchi S, Rhead WJ, Tanaka K, Hashimoto T. Cloning of human very-long-chain acyl-coenzyme A dehydrogenase and molecular characterization of its deficiency in two patients. <span><span class="ref-journal">Am J Hum Genet. </span>1995;<span class="ref-vol">57</span>:273–83.</span> [<a href="/pmc/articles/PMC1801555/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1801555</span></a>] [<a href="/pubmed/7668252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7668252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.aoyama.1993.1369">Aoyama T, Uchida Y, Kelley RI, Marble M, Hofman K, Tonsgard JH, Rhead WJ, Hashimoto T. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1993;<span class="ref-vol">191</span>:1369–72.</span> [<a href="/pubmed/8466512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8466512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.arnold.2009.85">Arnold GL, Van Hove J, Freedenberg D, Strauss A, Longo N, Burton B, Garganta C, Ficicioglu C, Cederbaum S, Harding C, Boles RG, Matern D, Chakraborty P, Feigenbaum A. A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">96</span>:85–90.</span> [<a href="/pmc/articles/PMC3219055/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3219055</span></a>] [<a href="/pubmed/19157942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19157942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.behrend.2012.110">Behrend AM, Harding CO, Shoemaker JD, Martern D, Sahn DJ, Elliot DL, Gillingham MB. Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">105</span>:110–5.</span> [<a href="/pmc/articles/PMC3253922/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3253922</span></a>] [<a href="/pubmed/22030098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22030098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.boneh.2006.166">Boneh A, Andresen BS, Gregersen N, Ibrahim M, Tzanakos N, Peters H, Yaplito-Lee J, Pitt JJ. VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">88</span>:166–70.</span> [<a href="/pubmed/16488171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16488171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.bonnet.1999.2248">Bonnet D, Martin D, De Lonlay P, Villain E, Jouvet P, Rabier D, Brivet M, Saudubray JM. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. <span><span class="ref-journal">Circulation. </span>1999;<span class="ref-vol">100</span>:2248–53.</span> [<a href="/pubmed/10577999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10577999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.diekman.2015.989">Diekman EF, Ferdinandusse S, van der Pol L, Waterham HR, Ruiter JP, Ijlst L, Wanders RJ, Houten SM, Wijburg FA, Blank AC, Asselbergs FW, Houtkooper RH, Visser G. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency. <span><span class="ref-journal">Genet Med. </span>2015;<span class="ref-vol">17</span>:989–94.</span> [<a href="/pubmed/25834949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25834949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.diekman.2016.101">Diekman E, de Sain-van der Velden M, Waterham H, Kluijtmans L, Schielen P, van Veen EB, Ferdinandusse S, Wijburg F, Visser G. The newborn screening paradox: sensitivity vs. overdiagnosis in VLCAD deficiency. <span><span class="ref-journal">JIMD Rep. </span>2016;<span class="ref-vol">27</span>:101–6.</span> [<a href="/pmc/articles/PMC4864775/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4864775</span></a>] [<a href="/pubmed/26453363" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26453363</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.gillingham.2006.58">Gillingham MB, Scott B, Elliott D, Harding CO. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">89</span>:58–63.</span> [<a href="/pmc/articles/PMC2706834/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2706834</span></a>] [<a href="/pubmed/16876451" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16876451</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.gobinlimballe.2007.1133">Gobin-Limballe S, Djouadi F, Aubey F, Olpin S, Andersen BS, Yamaguchi S, Mandel H, Fukao T, Ruiter JP, Wanders RJ, McAndrew R, Kim JJ, Bastin J. Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:1133–43.</span> [<a href="/pmc/articles/PMC2276345/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2276345</span></a>] [<a href="/pubmed/17999356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17999356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.goetzman.2007.138">Goetzman ES, Wang Y, He M, Mohsen AW, Ninness BK, Vockley J. Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic system. <span><span class="ref-journal">Mol Genet Metab. </span>2007;<span class="ref-vol">91</span>:138–47.</span> [<a href="/pmc/articles/PMC2702680/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2702680</span></a>] [<a href="/pubmed/17374501" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17374501</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.hale.1985.666">Hale DE, Batshaw ML, Coates PM, Frerman FE, Goodman SI, Singh I, Stanley CA. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. <span><span class="ref-journal">Pediatr Res. </span>1985;<span class="ref-vol">19</span>:666–71.</span> [<a href="/pubmed/4022672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4022672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.hall.2014.889">Hall PL, Marquardt G, McHugh DMS, Currier RJ, Tang H, Stoway DS, Rinaldo P. Post-analytical tool improve performance of newborn screening by tandem mass spectrometry. <span><span class="ref-journal">Genet Med. </span>2014;<span class="ref-vol">16</span>:889–95.</span> [<a href="/pmc/articles/PMC4262759/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4262759</span></a>] [<a href="/pubmed/24875301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24875301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.hoffman.2006.657">Hoffman JD, Steiner RD, Paradise L, Harding CO, Ding L, Strauss AW, Kaplan P. Rhabdomyolysis in the military: recognizing late-onset very long-chain acyl CoA dehydrogenase deficiency. <span><span class="ref-journal">Mil Med. </span>2006;<span class="ref-vol">171</span>:657–8.</span> [<a href="/pubmed/16895136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16895136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.lafor_t.2009.324">Lafor&#x000ea;t P, Acquaviva-Bourdain C, Rigal O, Brivet M, Penisson-Besnier I, Chabrol B, Chaigne D, Boespflug-Tanguy O, Laroche C, Bedat-Millet AL, Behin A, Delevaux I, Lomb&#x000e8;s A, Andresen BS, Eymard B, Vianey-Saban C. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:324–9.</span> [<a href="/pubmed/19327992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19327992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.martin.2014.139">Martin JM, Gillingham MB, Harding CO. Use of propofol for short duration procedures in children with long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiencies. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">112</span>:139–42.</span> [<a href="/pmc/articles/PMC4121654/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4121654</span></a>] [<a href="/pubmed/24780638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24780638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.mchugh.2011.230">McHugh D, Cameron CA, Abdenur JE, Abdulrahman M, Adair O, Al Nuaimi SA, &#x000c5;hlman H, Allen JJ, Antonozzi I, Archer S, Au S, Auray-Blais C, Baker M, Bamforth F, Beckmann K, Pino GB, Berberich SL, Binard R, Boemer F, Bonham J, Breen NN, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Cariappa R, Carlisle C, Caruso U, Cassanello M, Castilla AM, Ramos DE, Chakraborty P, Chandrasekar R, Ramos AC, Cheillan D, Chien YH, Childs TA, Chrastina P, Sica YC, de Juan JA, Colandre ME, Espinoza VC, Corso G, Currier R, Cyr D, Czuczy N, D'Apolito O, Davis T, de Sain-Van der Velden MG, Delgado Pecellin C, Di Gangi IM, Di Stefano CM, Dotsikas Y, Downing M, Downs SM, Dy B, Dymerski M, Rueda I, Elvers B, Eaton R, Eckerd BM, El Mougy F, Eroh S, Espada M, Evans C, Fawbush S, Fijolek KF, Fisher L, Franzson L, Frazier DM, Garcia LR, Bermejo MS, Gavrilov D, Gerace R, Giordano G, Irazabal YG, Greed LC, Grier R, Grycki E, Gu X, Gulamali-Majid F, Hagar AF, Han L, Hannon WH, Haslip C, Hassan FA, He M, Hietala A, Himstedt L, Hoffman GL, Hoffman W, Hoggatt P, Hopkins PV, Hougaard DM, Hughes K, Hunt PR, Hwu WL, Hynes J, Ibarra-Gonz&#x000e1;lez I, Ingham CA, Ivanova M, Jacox WB, John C, Johnson JP, J&#x000f3;nsson JJ, Karg E, Kasper D, Klopper B, Katakouzinos D, Khneisser I, Knoll D, Kobayashi H, Koneski R, Kozich V, Kouapei R, Kohlmueller D, Kremensky I, la Marca G, Lavochkin M, Lee SY, Lehotay DC, Lemes A, Lepage J, Lesko B, Lewis B, Lim C, Linard S, Lindner M, Lloyd-Puryear MA, Lorey F, Loukas YL, Luedtke J, Maffitt N, Magee JF, Manning A, Manos S, Marie S, Hadachi SM, Marquardt G, Martin SJ, Matern D, Mayfield Gibson SK, Mayne P, McCallister TD, McCann M, McClure J, McGill JJ, McKeever CD, McNeilly B, Morrissey MA, Moutsatsou P, Mulcahy EA, Nikoloudis D, Norgaard-Pedersen B, Oglesbee D, Oltarzewski M, Ombrone D, Ojodu J, Papakonstantinou V, Reoyo SP, Park HD, Pasquali M, Pasquini E, Patel P, Pass KA, Peterson C, Pettersen RD, Pitt JJ, Poh S, Pollak A, Porter C, Poston PA, Price RW, Queijo C, Quesada J, Randell E, Ranieri E, Raymond K, Reddic JE, Reuben A, Ricciardi C, Rinaldo P, Rivera JD, Roberts A, Rocha H, Roche G, Greenberg CR, Mellado JM, Juan-Fita MJ, Ruiz C, Ruoppolo M, Rutledge SL, Ryu E, Saban C, Sahai I, Garc&#x000ed;a-Blanco MI, Santiago-Borrero P, Schenone A, Schoos R, Schweitzer B, Scott P, Seashore MR, Seeterlin MA, Sesser DE, Sevier DW, Shone SM, Sinclair G, Skrinska VA, Stanley EL, Strovel ET, Jones AL, Sunny S, Takats Z, Tanyalcin T, Teofoli F, Thompson JR, Tomashitis K, Domingos MT, Torres J, Torres R, Tortorelli S, Turi S, Turner K, Tzanakos N, Valiente AG, Vallance H, Vela-Amieva M, Vilarinho L, von D&#x000f6;beln U, Vincent MF, Vorster BC, Watson MS, Webster D, Weiss S, Wilcken B, Wiley V, Williams SK, Willis SA, Woontner M, Wright K, Yahyaoui R, Yamaguchi S, Yssel M, Zakowicz WM. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. <span><span class="ref-journal">Genet Med. </span>2011;<span class="ref-vol">13</span>:230–54.</span> [<a href="/pubmed/21325949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21325949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.mendezfigueroa.2010.558">Mendez-Figueroa H, Shchelochkov OA, Shaibani A, Aagaard-Tillery K, Shinawi MS. Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy. <span><span class="ref-journal">J Perinatol. </span>2010;<span class="ref-vol">30</span>:558–62.</span> [<a href="/pubmed/20668464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20668464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.merritt.2014.484">Merritt JL 2nd, Vedal S, Abdenur JE, Au SM, Barshop BA, Feuchtbaum L, Harding CO, Hermerath C, Lorey F, Sesser DE, Thompson JD, Yu A. Infants suspected to have very-log chain acyl-CoA dehydrogenase deficiency from newborn screening. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">111</span>:484–92.</span> [<a href="/pubmed/24503138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24503138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.miller.2015.139">Miller MJ, Burrage LC, Gibson JB, Strenk ME, Lose EJ, Bick DP, Elsea SH, Sutton VR, Sun Q, Graham BH, Craigen WJ, Zhang VW, Wong LJ. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">116</span>:139–45.</span> [<a href="/pmc/articles/PMC4790081/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4790081</span></a>] [<a href="/pubmed/26385305" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26385305</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.pena.2016.272">Pena LD, van Calcar SC, Hansen J, Edick MJ, Walsh Vockley C, Leslie N, Cameron C, Mohsen AW, Berry SA, Arnold GL, Vockley J. IBEMC. Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database. <span><span class="ref-journal">Molecular genetics and metabolism. </span>2016;<span class="ref-vol">118</span>:272–81.</span> [<a href="/pmc/articles/PMC4970910/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4970910</span></a>] [<a href="/pubmed/27209629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27209629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.pervaiz.2011.29">Pervaiz MA, Kendal F, Hegde M, Singh RH. MCT oil-based diet reverses hypertrophic cardiomyopathy in a patient with very long chain acyl-coA dehydrogenase deficiency. <span><span class="ref-journal">Indian J Hum Genet. </span>2011;<span class="ref-vol">17</span>:29–32.</span> [<a href="/pmc/articles/PMC3144685/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3144685</span></a>] [<a href="/pubmed/21814341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21814341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.primassin.2008.632">Primassin S, Ter Veld F, Mayatepek E, Spiekerkoetter U. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine. <span><span class="ref-journal">Pediatr Res. </span>2008;<span class="ref-vol">63</span>:632–7.</span> [<a href="/pubmed/18317232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18317232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.roe.2006.40">Roe DS, Yang BZ, Vianey-Saban C, Struys E, Sweetman L, Roe CR. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">87</span>:40–7.</span> [<a href="/pubmed/16297647" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16297647</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.solis.2002.1800">Solis JO, Singh RH. Management of fatty acid oxidation disorders: a survey of current treatment strategies. <span><span class="ref-journal">J Am Diet Assoc. </span>2002;<span class="ref-vol">102</span>:1800–3.</span> [<a href="/pubmed/12487544" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12487544</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.spiekerkoetter.2009.498">Spiekerkoetter U, Linder M, Santer R, Grotzke M, Baumgartner MR, Boehles H, Das A, Haase C, Hennemann JB, Karall D, de Klerk H, Knerr I, Koch HG, Plecko B, Roschinger W, Schwab KO, Scheible D, Wijburg FA, Zschocke J, Mayatepek E, Wendel U. Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009;<span class="ref-vol">32</span>:498–505.</span> [<a href="/pubmed/19452263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19452263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.strauss.1995.10496">Strauss AW, Powell CK, Hale DE, Anderson MM, Ahuja A, Brackett JC, Sims HF. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1995;<span class="ref-vol">92</span>:10496–500.</span> [<a href="/pmc/articles/PMC40638/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC40638</span></a>] [<a href="/pubmed/7479827" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7479827</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.vellekoop.2011.96">Vellekoop P, Diekman EF, van Tuijl I, de Vries MMC, van Hasselt PM, Visser G. Perioperative measures in very long chain acyl-CoA dehydrogenase deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">103</span>:96–7.</span> [<a href="/pubmed/21333574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21333574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.vockley.2017.370">Vockley J, Burton B, Berry GT, Longo N, Phillips J, Sanchez-Valle A, Tanpaiboon P, Grunewald S, Murphy E, Humphrey R, Mayhew J, Bowden A, Zhang L, Cataldo J, Marsden DL, Kakkis E. UX007 for the treatment of long chain-fatty acid oxidation disorders: safety and efficacy in children and adults following 24 weeks of treatment. <span><span class="ref-journal">Mol Genet Metab. </span>2017;<span class="ref-vol">120</span>:370–7.</span> [<a href="/pubmed/28189603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28189603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.vockley.2016.223">Vockley J, Charrow J, Ganesh J, Eswara M, Diaz GA, McCracken E, Conway R, Enns GM, Starr J, Wang R, Abdenur JE, Sanchez-de-Toledo J, Marsden DL. Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders. <span><span class="ref-journal">Mol Genet Metab. </span>2016;<span class="ref-vol">119</span>:223–231.</span> [<a href="/pmc/articles/PMC5083220/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5083220</span></a>] [<a href="/pubmed/27590926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27590926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vlcad.REF.zweers.2012.127">Zweers H, Timmer C, Rasmussen E, den Heijer M, de Valk H. Successful weight loss in two adult patients diagnosed with late-onset long-chain Fatty Aid oxidation defect. <span><span class="ref-journal">JIMD Rep. </span>2012;<span class="ref-vol">6</span>:127–9.</span> [<a href="/pmc/articles/PMC3565639/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3565639</span></a>] [<a href="/pubmed/23430950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430950</span></a>]</div></li></ul></div></div><div id="vlcad.Chapter_Notes"><h2 id="_vlcad_Chapter_Notes_">Chapter Notes</h2><div id="vlcad.Author_History"><h3>Author History</h3><p>Jessica A Connor, MS; Counsyl, Inc (2014-2017)<br />Nancy D Leslie, MD (2009-present)<br />Kerry Shooner, MS, CGC; Cincinnati Children's Hospital Medical Center (2009-2014)<br />Arnold W Strauss, MD (2009-present)<br />Brad T Tinkle, MD, PhD; Cincinnati Children's Hospital Medical Center (2009-2014)<br />C Alexander Valencia, PhD (2014-present)<br />Kejian Zhang, MD, MBA (2009-present)</p></div><div id="vlcad.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>23 May 2019 (aa) Revision: <i>TANGO2</i>-related metabolic encephalopathy and arrhythmias added to <a href="#vlcad.Differential_Diagnosis">Differential Diagnosis</a></div></li><li class="half_rhythm"><div>4 January 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 September 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 September 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 May 2009 (me) Review posted live</div></li><li class="half_rhythm"><div>29 December 2008 (ks) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK6816</span><span class="label">PMID: <a href="/pubmed/20301763" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301763</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/eds4/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vhl/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK6816&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK6816/?report=reader">PubReader</a></li><li><a href="/books/NBK6816/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK6816" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK6816" style="display:none" title="Cite this Page"><div class="bk_tt">Leslie ND, Valencia CA, Strauss AW, et al. Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. 2009 May 28 [Updated 2019 May 23]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK6816/pdf/Bookshelf_NBK6816.pdf">PDF version of this page</a> (207K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#vlcad.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#vlcad.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#vlcad.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#vlcad.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#vlcad.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#vlcad.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#vlcad.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#vlcad.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#vlcad.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#vlcad.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#vlcad.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=37[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ACADVL</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK6816+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1518244" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1518244" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1518244" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1518244" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301597" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Merritt JL 2nd, Chang IJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29369572" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TANGO2</i>-Related Metabolic Encephalopathy and Arrhythmias</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TANGO2</i>-Related Metabolic Encephalopathy and Arrhythmias<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lalani SR, Graham B, Burrage L, Lai YC, Scaglia F, Soler-Alfonso C, Miyake C, Yang Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301700" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bennett MJ, Santani AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301763" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301763" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0412b7dd21425a25b91fce">Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:53:59-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CC7C3E040F1110000000001920088&amp;ncbi_session=CE8CC7C3E0412B71_0402SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK6816%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK6816&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK6816/&amp;ncbi_pagename=Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CC7C3E0412B71_0402SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>